5 April 2022 in Clinical Immunology Communications
In Pakistan, the Hepatitis E virus (HEV) is prevalent. HEV exposure is deadly during pregnancy, with high infection rates in both the mother and the baby, even in asymptomatic situations. The researcher examined HEV-negative pregnant women with acute hepatitis or increased renal characteristic assessments at 12 medical sites in Khyber Pakhtunkhwa, Pakistan, to identify maternal and fetal disease risks from August to December 2018. Except for one during the entire pregnancy, twenty-five of the 135 females were HEV-free and in the perinatal period. HEV infection was found in 0.19% of newly pregnant women. Also, 11 cases of forcible induction of labour, 7 cases of normal labour, 5 cases of normal labour (full-term), 2 cases of death, and 1 case of intrauterine death were reported before going to the doctor a girl had an abortion. There were eight postpartum deaths: five from infections, four from miscarriages, and two from miscarriages. While 18 mothers who survived voluntarily or intentionally induced abortions and three women who continued to get pregnant but did not deliver died as a result of abortion. The current study found that HEV infection during pregnancy raised the death rate by 14.2%.
2 May 2023 in The Professional Medical Journal
Objective: To estimate the frequency of thrombocytopenia among patients with vivax-positive malaria. Study Design: Cross Sectional Study. Setting: Department of General Medicine Hayatabad Medical Complex Peshawar. Period: May 2022 to November 2022. Material & Methods: Total 140 cohort were observed in this study. Patients were taken as sample according to inclusion and exclusion criteria as per operational definition after the patients' written informed consent. Sociodemographic data was collected on a predesigned questionnaire. History such as febrile illnesses and blood dyscrasias and basic studies and peripheral blood smears were obtained. Results: The results of the study showed the sample has mean age 36 years with SD ± 3.72, of which 70% were men while 30% were women. Thrombocytopenia was observed in 68% of patients. Conclusion: In conclusion, the estimated frequency of thrombocytopenia in vivax malaria was found to be 68%.